NDC 55513-065 – Pavblu
Aflibercept 2 mg/.05mL · Injection, Solution · Intravitreal
Product NDC55513-065
Product details
- Brand name
- Pavblu
- Generic name
- aflibercept-ayyh
- Labeler
- Amgen, Inc
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Marketing category
- BLA · BLA761298
- Marketed since
- October 28, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Aflibercept 2 mg/.05mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 55513-065-01 | 1 VIAL in 1 CARTON (55513-065-01) / .05 mL in 1 VIAL | Oct 28, 2024 |
| 55513-065-96 | 1 VIAL in 1 CARTON (55513-065-96) / .05 mL in 1 VIAL | Oct 28, 2024 |
Other Pavblu products
- 55513-056 Aflibercept 2 mg/.05mL · Injection, Solution · Amgen, Inc